发明申请
- 专利标题： Compounds for the Treatment of Hepatitis C
- 专利标题（中）： 用于治疗丙型肝炎的化合物
-
申请号： US12046030申请日： 2008-03-11
-
公开(公告)号： US20080226592A1公开(公告)日： 2008-09-18
- 发明人: Kap-Sun Yeung , John A. Bender , Robert G. Gentles , Zhong Yang , Min Ding , Yong Tu , Piyasena Hewawasam , Ying Han , John F. Kadow
- 申请人： Kap-Sun Yeung , John A. Bender , Robert G. Gentles , Zhong Yang , Min Ding , Yong Tu , Piyasena Hewawasam , Ying Han , John F. Kadow
- 专利权人： Bristol-Myers Squibb Company
- 当前专利权人： Bristol-Myers Squibb Company
- 主分类号： A61K31/55
- IPC分类号： A61K31/55 ; C07D487/04 ; A61P31/12 ; A61K38/21 ; A61K38/20
摘要：
The invention encompasses compounds of Formula I, pharmaceutically acceptable salts thereof, compositions, and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.
公开/授权文献
- US07538102B2 Compounds for the treatment of Hepatitis C 公开/授权日：2009-05-26
信息查询
